Bloodsampling

OTHER5 trials

Sponsors

Sandoz, Radboud University Medical Center, University Hospital, Antwerp, Assistance Publique Hopitaux De Marseille, Erasmus Medical Center

Conditions

Breast CancerFBN1 MutationMarfan SyndromeMetastatic Castration-resistant Prostate CarcinomaShort Children Born Small for Gestational Age (SGA)Solid CancersSolid Tumor Malignanciesleukaemia and central nervous system lymphoma acute leukemie en centraal zenuwstelsel lymfoom

Unknown Phase

Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age

TerminatedNCT01491854

SandozShort Children Born Small for Gestational Age (SGA)

Start: 2009-07-20End: 2018-10-31Updated: 2019-08-14

Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity

CompletedNCT01621425

Radboud University Medical CenterBreast Cancer, Metastatic Castration-resistant Prostate Carcinoma

Start: 2012-06-30End: 2015-05-31Updated: 2015-08-13

Intracellular drug measurements to predict toxicity in high-dose methotrexate therapy in leukaemia and central nervous system lymphoma.

Active, not recruitingNL-OMON24644

Erasmus Medical Centerleukaemia and central nervous system lymphoma acute leukemie en centraal zenuwstelsel lymfoom

Start: 2016-01-01Target: 60Updated: 2024-02-28

Genome-wide Epistasis for Cardiovascular Severity in Marfan Study

RecruitingNCT06257004

University Hospital, AntwerpFBN1 Mutation, Marfan Syndrome

Start: 2020-11-30End: 2025-10-31Target: 200Updated: 2024-02-13

Predicting Reactions and Effects of Drugs Immunotherapy and Complications Through Oncosafety (PREDICTO Clinical Study)

Not yet recruitingNCT07192315

Assistance Publique Hopitaux De MarseilleSolid Cancers, Solid Tumor Malignancies

Start: 2026-04-01End: 2028-01-01Target: 160Updated: 2026-03-13